Kate approaches her work with a balance of idealism and pragmatism, passionate about increasing access to essential medicines for people who need them, but always examining the big picture before developing measured, realistic solutions.
These qualities have made Kate a trusted advisor for the firm’s clients in the life sciences industry. In her role at Rabin Martin, she leads a growing team in addressing the full spectrum of the access to medicines challenge – from policy to implementation, pricing to intellectual property, stakeholder engagement to communications – for infectious diseases, vaccines and non-communicable diseases. Kate specializes in:
- Creating strategies for advocacy and adoption of new products and technologies
- Navigating the complex global health ecosystem to affect health outcomes
- Building frameworks to foster sustainable mechanisms for change
- Convening key stakeholders to address health policies and emerging health issues
An experienced communications professional, Kate has worked at the intersection of policy and public affairs for a number of years in the private and public sectors. Prior to her work at Rabin Martin, Kate served as Deputy Press Secretary with the New York City Campaign Finance Board, where she supported the agency’s media relations and public communications. Kate has also consulted for Think-21, a renewable energy product development start-up, and has worked for a number of law firms as well as a national NGO focused on consumer product safety.
The George Washington University